New York, NY (PRWEB) February 17, 2013
Johnson & Johnson has once again recalled thousands of metal-on-metal hip implants, Bernstein Liebhard LLP reports. According to the Associated Press, the new recall involves the “Adept” hip implant, an all-metal total hip replacement system the company sold abroad that was found to have a higher-than-expected revision rate. This marks the second time Johnson & Johnson has pulled an all-metal hip from the market. In August 2010, the company announced the DePuy ASR hip recall after those devices were found to have an unacceptably high revision rate. Johnson & Johnson and its DePuy Orthopaedics unit are also facing thousands of DePuy Pinnacle hip replacement lawsuits involving a metal-on-metal version of its Pinnacle hip implant system.*
“While none of the Adept products were sold in the U.S., this new recall just underscores the risks associated with metal-on-metal hip replacements,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing DePuy ASR hip lawsuits in a federal multidistrict litigation underway in U.S. District Court, Northern District of Ohio. (In re DePuy Orthopedics Inc., ASR Hip Implant Products Liability Litigation, MDL 2197) In addition, Bernstein Liebhard LLP partner Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee in the federal DePuy Pinnacle litigation underway in U.S. District Court, Northern District of Texas. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)
Metal-on-Metal Hip Implants
Metal-on-metal hip replacements consist of a chromium/cobalt ball and cup. On January 17, 2013, the U.S. Food & Drug Administration (FDA) issued new guidance for patients with such devices, advising doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. According to the agency, metal debris released as a result of friction between the ball and cup may cause damage to bone and/or soft tissue surrounding the implant and joint. Some of the metal ions released will enter the bloodstream and travel to other parts of the body, where they may cause symptoms or illnesses elsewhere in the body. The FDA has also proposed a new regulation that would make all-metal hips ineligible for its 510(k) approval system, which allowed products like the ASR and metal-on-metal Pinnacle to come to market without human testing.**
Victims of alleged metal-on-metal hip replacement injuries may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. In addition to its work on DePuy hip replacement lawsuits, Bernstein Liebhard LLP is also offering free case evaluations to patients impacted by the July 2012 Stryker Rejuvenate hip recall, and the June 2012 Smith & Nephew metal liner recall. In addition, the Firm continues to investigate cases concerning the Biomet M2a Magnum hip implant, as well as Wright Profemur and Conserve metal hip implants.
A wealth of information about metal-on-metal hip implants is available on Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/ . For additional information, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP